Hot Pursuit     06-Feb-25
Zydus Lifesciences Ltd gains for third straight session
Zydus Lifesciences Ltd is quoting at Rs 1018.55, up 4.25% on the day as on 12:49 IST on the NSE. The stock is up 28.67% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the Nifty Pharma index.

Zydus Lifesciences Ltd gained for a third straight session today. The stock is quoting at Rs 1018.55, up 4.25% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.41% on the day, quoting at 23600.05. The Sensex is at 77920.62, down 0.45%. Zydus Lifesciences Ltd has gained around 1.77% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 5.07% in last one month and is currently quoting at 21868.5, up 0.83% on the day. The volume in the stock stood at 41.26 lakh shares today, compared to the daily average of 12.66 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 1018.65, up 3.95% on the day. Zydus Lifesciences Ltd is up 28.67% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the Nifty Pharma index.

The PE of the stock is 22.51 based on TTM earnings ending December 24.

Previous News
  Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session
 ( Hot Pursuit - 03-Dec-24   13:06 )
  Zydus Life spurts on reporting robust Q4 numbers
 ( Hot Pursuit - 18-May-24   11:41 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Barometers end with minor gains; broader mkt outperforms
 ( Market Commentary - Quick Review 18-May-24   12:44 )
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 02-Jan-24   13:05 )
  Zydus Lifesciences Ltd soars 0.09%, rises for fifth straight session
 ( Hot Pursuit - 30-Jun-23   13:00 )
  Zydus Life gets zero observation from USFDA for Ahmedabad facility
 ( Hot Pursuit - 03-Jun-23   12:33 )
  Zydus Lifesciences Ltd slips for fifth straight session
 ( Hot Pursuit - 30-May-24   13:35 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease
 ( Corporate News - 15-Oct-24   10:08 )
  Zydus Life gets USFDA nod for Erythromycin tablets
 ( Hot Pursuit - 10-Mar-23   09:18 )
Other Stories
  NACL Industries jumps 111% in fifteen days
  22-Apr-25   14:58
  Parshva Enterprises Ltd leads losers in 'B' group
  22-Apr-25   14:45
  Indo Amines edges higher after launching new product aliphatic amines category
  22-Apr-25   14:42
  Volumes soar at Asahi India Glass Ltd counter
  22-Apr-25   14:30
  Panorama Studios jumps on bagging distribution rights for "Kesari Veer"
  22-Apr-25   14:16
  Information Technology shares fall
  22-Apr-25   14:00
  TCS inks agreement with ICICI Securities for upgrading its retail trading platform
  22-Apr-25   13:42
  HMA Agro Industries gains on appointing Gulzeb Ahmed as CEO
  22-Apr-25   13:27
  HUL gains on acquiring 90.5% stake in Uprising Science for Rs 2,706 crore
  22-Apr-25   13:24
  Mahindra & Mahindra Ltd soars 1.45%, rises for third straight session
  22-Apr-25   13:05
Back Top